Perspective Therapeutics (STU:AAJ0) Institutional Ownership: 30.73% (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:AAJ0 Perspective Therapeutics Inc STU:AAJ0
35 GF Score
Price €2.66
GF Value €0.68
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Perspective Therapeutics Institutional Ownership?

Perspective Therapeutics STU:AAJ0 -1.99% 35 Institutional Ownership is 30.73% as of Aug. 31, 2026. GuruFocus rates STU:AAJ0 with a GF Score™ of 35/100 and a GF Value™ of €0.68 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Perspective Therapeutics's institutional ownership is 30.73%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Perspective Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Perspective Therapeutics's Float Percentage Of Total Shares Outstanding is 83.73%.

Perspective Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Perspective Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perspective Therapeutics Institutional Ownership Chart

Perspective Therapeutics Historical Data

The historical data trend for Perspective Therapeutics can be seen below:

2025-09-30 2025-10-31 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 38.24 34.51 22.74 22.84 15.30 22.48 34.61 34.95 29.41 30.73
STU:AAJ0
35GF Score
Perspective Therapeutics Inc STU:AAJ0
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perspective Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 30.73% mean?
Perspective Therapeutics (STU:AAJ0) has a Institutional Ownership of 30.73% as of Aug. 31, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Perspective Therapeutics and its competitors.
Is Perspective Therapeutics' Institutional Ownership too high?
Perspective Therapeutics' current Institutional Ownership is 30.73%. Overall, Perspective Therapeutics has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Perspective Therapeutics' Institutional Ownership compare to VMD and MOBI?
Perspective Therapeutics' Institutional Ownership of 30.73% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Perspective Therapeutics and its competitors. Perspective Therapeutics's current Institutional Ownership is 30.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perspective Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Perspective Therapeutics (STU:AAJ0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.68, compared to a current price of €2.66 — trading 291.2% above its estimated fair value. The current Institutional Ownership is 30.73%. Perspective Therapeutics' overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Perspective Therapeutics (STU:AAJ0), the current Institutional Ownership is 30.73% as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perspective Therapeutics (STU:AAJ0) Overvalued in 2026?

Based on GuruFocus' analysis, Perspective Therapeutics stock appears to be overvalued. The current stock price of €2.66 is trading 291.2% above its estimated GF Value™ of €0.68. GuruFocus considers Perspective Therapeutics to be Significantly Overvalued.

Key valuation signals for STU:AAJ0:

  • Institutional Ownership: 30.73%
  • GF Value™: €0.68 vs. price of €2.66 (291.2% above fair value)
  • GF Score™: 35/100 with 1 warning sign

No single metric tells the full story. See the STU:AAJ0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perspective Therapeutics Business Description

Other Exchanges CATX:USAAAJ0:Germany
Address 2401 Elliott Avenue, Suite 320, Seattle, WA, USA, 98121
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
35GF Score

Get the complete analysis for STU:AAJ0

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.66
Price
€0.68
GF Value